Tender Spain

Framework Agreement for the provision of a multigene test for patients with localised breast cancer, prognostic and predictive therapeutic assessment, Pathology Department, 2a+2pr

Reference 482539-2026
Official title

Original title: Acuerdo Marco prestación test multigénico pacientes cáncer de mama localizado valoración pronóstica y predictiva terapéutica s. anatomía patológica 2a+2pr

Inspección General de Sanidad de la Defensa Published auto-extracted, not yet reviewed

At a glance

Instrument
Tender

Classification CPV 33690000

Summary

A framework agreement for the provision of a multigene test to assess prognosis and predict therapeutic response in patients with localised breast cancer, for the Pathology Department. The term is stated as 2a+2pr in the notice.

PRO

This item is older than 14 days. Full details are in Pro.

Pro members get the full archive, eligibility & budget breakdowns, award data, weekly analyst brief and CSV/API export.

See pricing

Dates in this notice

  1. Published
  2. Deadline

Check the notice for the submission stage and exact time.

Organisations in this notice

This noticeTender482539-2026

Source & methodology

Source: Tenders Electronic Daily © European Union, reused under EU open data policy. Notice 482539-2026.

Structured automatically from the source notice; not yet reviewed by an analyst.